Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study

Background: The current outbreak of coronavirus disease 2019 (COVID-19) has quickly spread across countries and become a global crisis. However, one of the most important clinical characteristics in epidemiology, the distribution of the incubation period, remains unclear. Different estimates of the incubation period of COVID-19 were reported in recent published studies, but all have their own limitations. In this study, we propose a novel low-cost and accurate method to estimate the incubation distribution. Methods: We have conducted a cross-sectional and forward follow-up study by identifying those asymptomatic individuals at their time of departure from Wuhan and then following them until their symptoms developed. The renewal process is hence adopted by considering the incubation period as a renewal and the duration between departure and symptom onset as a forward recurrence time. Under mild assumptions, the observations of selected forward times can be used to consistently estimate the parameters in the distribution of the incubation period. Such a method enhances the accuracy of estimation by reducing recall bias and utilizing the abundant and readily available forward time data. Findings: The estimated distribution of forward time fits the observations in the collected data well. The estimated median of incubation period is 8.13 days (95% confidence interval [CI]: 7.37-8.91), the mean is 8.62 days (95% CI: 8.02-9.28), the 90th percentile is 14.65 days (95% CI: 14.00-15.26), and the 99th percentile is 20.59 days (95% CI: 19.47, 21.62). Compared with results in other studies, the incubation period estimated in this study is longer. Interpretation: Based on the estimated incubation distribution in this study, about 10% of patients with COVID-19 would not develop symptoms until 14 days after infection. Further study of the incubation distribution is warranted to directly estimate the proportion with long incubation periods.

[1]  Yan Bai,et al.  Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.

[2]  N. Linton,et al.  Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data , 2020, medRxiv.

[3]  Jieun Park,et al.  MERS transmission and risk factors: a systematic review , 2018, BMC Public Health.

[4]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[5]  C. Fraser,et al.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong , 2003, The Lancet.

[6]  Benjamin J Cowling,et al.  A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan , 2010, BMC infectious diseases.

[7]  B J Cowling,et al.  Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[9]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[10]  A. Hedley,et al.  Title Epidemiology of SARS in the 2003 Hong Kong epidemic , 2022 .

[11]  J. Sureshkumar,et al.  Novel Coronavirus , 2020, Research Journal of Pharmacology and Pharmacodynamics.

[12]  A. Vespignani,et al.  Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study , 2020, The Lancet Infectious Diseases.

[13]  Qiushi Lin,et al.  Estimating the daily trend in the size of the COVID-19 infected population in Wuhan , 2020, Infectious Diseases of Poverty.

[14]  D. Cummings,et al.  Hospital outbreak of Middle East respiratory syndrome coronavirus. , 2013, The New England journal of medicine.

[15]  M. Meltzer,et al.  Multiple Contact Dates and SARS Incubation Periods , 2004, Emerging infectious diseases.

[16]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[17]  Benjamin J. Cowling,et al.  Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia , 2016, Scientific Reports.

[18]  William Feller,et al.  An Introduction to Probability Theory and Its Applications , 1951 .

[19]  N. Linton,et al.  Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data , 2020, medRxiv.

[20]  Don Klinkenberg,et al.  Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  J. Qin Biased sampling, over-identified parameter problems and beyond , 2017 .

[22]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[23]  Yongsheng Wu,et al.  Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study , 2020, The Lancet Infectious Diseases.

[24]  Jianming Xu,et al.  Refined Estimate of the Incubation Period of Severe Acute Respiratory Syndrome and Related Influencing Factors , 2005, American journal of epidemiology.

[25]  Stefan Ma,et al.  The estimation of SARS incubation distribution from serial interval data using a convolution likelihood , 2005, Statistics in medicine.

[26]  S. Yi,et al.  Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[27]  C. Eastin,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.

[28]  Zijian Feng,et al.  Epidemic Update and Risk Assessment of 2019 Novel Coronavirus — China, January 28, 2020 , 2020, China CDC weekly.